2025 has been a landmark year for cancer research. From an AI model predicting immunotherapy response from a routine blood test to personalised mRNA cancer vaccines reducing recurrence risk by 44 percent — here are the 7 biggest verified breakthroughs of the year, what they mean, and what they could mean for patients.

Cancer immunotherapy has transformed oncology more profoundly than any development since chemotherapy — turning once-fatal metastatic melanoma into a survivable disease for some patients. This plain-language guide explains how checkpoint inhibitors, CAR-T cell therapy, cancer vaccines, and monoclonal antibodies work and which cancers they treat.

Drug repurposing is one of the most active areas of modern oncology — investigating existing medicines for potential anti-cancer properties. This evidence-based guide covers proven successes like Thalidomide for multiple myeloma, current frontrunners like Metformin, and the critical distinction between laboratory findings and clinical proof that every patient should understand.

A dog deworming drug sparking global cancer treatment conversations — is fenbendazole the breakthrough patients are hoping for, or dangerous misinformation? This evidence-based guide covers the latest 2026 research, real risks, and what cancer patients in India need to know before considering it.